Sources
Additional media
Loading...
The Supreme Court's recent decision to end the Chevron Doctrine is poised to significantly impact regulatory accountability and business regulation. The Chevron Doctrine, which has long allowed federal agencies to interpret ambiguous statutes, is now under scrutiny. This change is expected to affect intellectual property (IP) and antitrust enforcement, with increased attention on third-party pricing facilitators. Legal experts from Goodwin Law and Venable LLP have highlighted the potential consequences for various sectors, including healthcare.